These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10756782)

  • 1. [Antilipemic therapy in dyslipidemias in obese non-insulin-dependent diabetics (ONIDDM)].
    Palel G; Coman A; Petrovanu R; Ungureanu D; Cojocaru M
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):120-2. PubMed ID: 10756782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic effects of hypolipemic drugs on aged type 2 diabetes].
    Palel G; Coman A; Petrovanu R; Ungureanu D
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(3):518-20. PubMed ID: 12092185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of antilipemic therapy on patients with diabetes mellitus and obesity].
    Ungureanu D; Coman A; Maftei M; Popovici I; Artenie A; Artenie R
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):551-5. PubMed ID: 14756060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dyslipidemia and hyperinsulinemia in normoglycemic-obese relatives of patients with non-insulin dependent diabetes mellitus].
    Florez H; Valbuena H; Ryder E; Rincón E; Campos G; Castillo S; González J; Fernández V; Raleigh X; Gómez ME
    Invest Clin; 1995 Sep; 36(3):131-47. PubMed ID: 7548306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study.
    Fasching P; Rohac M; Liener K; Schneider B; Nowotny P; Waldhäusl W
    Horm Metab Res; 1996 May; 28(5):230-6. PubMed ID: 8738112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliclazide in the treatment of obese non-insulin dependent diabetic patients.
    Seshiah V; Venkataraman S; Suresh K
    J Assoc Physicians India; 1993 Jun; 41(6):367-8. PubMed ID: 8005974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Black soybean extract improves lipid profiles in fenofibrate-treated type 2 diabetics with postprandial hyperlipidemia.
    Kusunoki M; Sato D; Tsutsumi K; Tsutsui H; Nakamura T; Oshida Y
    J Med Food; 2015 Jun; 18(6):615-8. PubMed ID: 25651043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of dyslipidemia and platelet adhesiveness in non-insulin dependent diabetes mellitus.
    Kurhade GA; Waghmare P; Phatak MS; Gosavi GB
    Indian J Physiol Pharmacol; 2000 Apr; 44(2):167-72. PubMed ID: 10846630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofibrate and lipid profile.
    Chandler HA; Batchelor AJ
    Lancet; 1994 Jul; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemia.
    Geiss HC; Dietlein M; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):322-4. PubMed ID: 14520596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Qualitative and quantitiative differences in the plasma lipoproteins of obese, hyperlipidemic or normolipidemic men and women].
    Fernández V; Campos G; Rincón E; Valbuena H; Ryder E; Gomez ME; Raleigh X
    Invest Clin; 1996 Mar; 37(1):17-34. PubMed ID: 8920029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
    Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C
    Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for fibrate therapy in diabetes: evidence before FIELD.
    Vergès B
    Curr Opin Lipidol; 2005 Dec; 16(6):648-51. PubMed ID: 16276243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrates and HDL cholesterol.
    Murphy MJ; Packard CJ; O'Reilly DS
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():114. PubMed ID: 9022900
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical high-density lipoprotein reduction induced by fenofibrate and ciprofibrate.
    Collinson PO; Hjelm CJ; Canepo-Anson R
    Ann Clin Biochem; 1996 Mar; 33 ( Pt 2)():159-61. PubMed ID: 8729728
    [No Abstract]   [Full Text] [Related]  

  • 20. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.